Patients with systemic sclerosis (SSc), poly-/dermatomyositis (PM/DM), or rheumatoid arthritis (RA) appear to carry the greatest risk for developing connective tissue disease-associated interstitial lung disease (CTD-ILD)
Search results for: dermatomyositis
Nomenclature, Semantics, Jargon, Lingo, Eponyms, Etymology, and Terminology in Rheumatology
Why rheumatologists must coin simple, comprehensible terms for what we read, speak and write to our patients
Morris Reichlin Contributes Five Decades of Immunologic Advances in Rheumatology
Career marked by the quest to define the antigenic targets of autoimmunity in people with systemic lupus erythematosus (SLE), inflammatory myopathies, polymyositis, and dermatomyositis
EULAR 2012: Partnership Between Physician and Patient
Patient involvement a valuable tool, especially in less common rheumatic disorders.
Inflammatory Myopathies in Children
Treatment options and recent research for juvenile dermatomyositis.
Award Targets Critical Shortage of Pediatric Rheumatologists
Deborah Rothman, MD, PhD, received two separate ACR REF/Amgen Pediatric Rheumatology Visiting Professorship Awards, which allowed her to visit programs that do not have either a pediatric rheumatologist or a pediatric rheumatology fellowship program.
The Mystery of IVIg
Although initially given as replacement therapy for patients with primary and secondary immunodeficiency states, intravenous immunoglobulin (IVIg) has proven to be effective in the treatment of various autoimmune and inflammatory disorders. This success has led to a dramatic increase in the use of IVIg, with its use as an antiinflammatory agent now vastly surpassing its use in the treatment of immunodeficiencies. Even so, the basis for the antiinflammatory activity of IVIg remains unclear.
Meet the Challenge of Primary CNS Vasculitis
Diagnosis and treatment of this rare and poorly understood condition
ACR Member Named PPAC Physician Researcher of the Year
Captain Lisa Rider, MD, a physician-scientist and clinical researcher at the National Institute of Environmental Health Sciences in Bethesda, Md., was named 2011 Physician Researcher of the Year by the Physicians Professional Advisory Committee of the United States Public Health Service. The award was presented in recognition of her basic and clinical research into myositis. Her recent research findings have included: definitions of improvement as a primary composite endpoint for myositis clinical trials, discovery of a novel autoantibody in juvenile dermatomyositis and discovery of new immunogenetic risk factors for juvenile myositis. Her epidemiologic and clinical studies in myositis have made substantial contributions to public health practice.
Capillaroscopy a Safe and Direct Method for SSc Diagnosis
Seeing vessels clearly can help with discovery and timely treatment